Cargando…

GDF-15 plasma levels in chronic obstructive pulmonary disease are associated with subclinical coronary artery disease

BACKGROUND: Growth differentiation factor-15 (GDF-15), a cytokine associated with cardiovascular mortality, increases during chronic obstructive pulmonary disease (COPD) exacerbations, but any role in stable COPD is unknown. We tested associations between GDF-15 and subclinical coronary atherosclero...

Descripción completa

Detalles Bibliográficos
Autores principales: Martinez, Carlos H., Freeman, Christine M., Nelson, Joshua D., Murray, Susan, Wang, Xin, Budoff, Matthew J., Dransfield, Mark T., Hokanson, John E., Kazerooni, Ella A., Kinney, Gregory L., Regan, Elizabeth A., Wells, J. Michael, Martinez, Fernando J., Han, MeiLan K., Curtis, Jeffrey L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5331711/
https://www.ncbi.nlm.nih.gov/pubmed/28245821
http://dx.doi.org/10.1186/s12931-017-0521-1
_version_ 1782511432626077696
author Martinez, Carlos H.
Freeman, Christine M.
Nelson, Joshua D.
Murray, Susan
Wang, Xin
Budoff, Matthew J.
Dransfield, Mark T.
Hokanson, John E.
Kazerooni, Ella A.
Kinney, Gregory L.
Regan, Elizabeth A.
Wells, J. Michael
Martinez, Fernando J.
Han, MeiLan K.
Curtis, Jeffrey L.
author_facet Martinez, Carlos H.
Freeman, Christine M.
Nelson, Joshua D.
Murray, Susan
Wang, Xin
Budoff, Matthew J.
Dransfield, Mark T.
Hokanson, John E.
Kazerooni, Ella A.
Kinney, Gregory L.
Regan, Elizabeth A.
Wells, J. Michael
Martinez, Fernando J.
Han, MeiLan K.
Curtis, Jeffrey L.
author_sort Martinez, Carlos H.
collection PubMed
description BACKGROUND: Growth differentiation factor-15 (GDF-15), a cytokine associated with cardiovascular mortality, increases during chronic obstructive pulmonary disease (COPD) exacerbations, but any role in stable COPD is unknown. We tested associations between GDF-15 and subclinical coronary atherosclerosis, assessed by coronary artery calcium (CAC) score, in COPD subjects free of clinical cardiovascular disease (CVD). METHODS: Cross-sectional analysis of COPD participants (GOLD stages 2–4) in the COPDGene cohort without CVD at enrollment, using baseline CAC (from non-EKG-gated chest computed tomography) and plasma GDF-15 (by custom ELISA). We used multinomial logistic modeling of GDF-15 associations with CAC, adjusting for demographics, baseline risk (calculated using the HEART: Personal Heart Early Assessment Risk Tool (Budoff et al. 114:1761-1791, 2006) score), smoking history, measures of airflow obstruction, emphysema and airway disease severity. RESULTS: Among 694 participants with COPD (47% women, mean age 63.6 years) mean GDF-15 was 1,304 pg/mL, and mean CAC score was 198. Relative to the lower GDF-15 tertile, higher tertiles showed bivariate association with increasing CAC score (mid tertile odds ratio [OR] 1.80, 95% confidence interval [CI] 1.29, 2.51; higher tertile OR 2.86, CI 2.04, 4.02). This association was maintained after additionally adjusting for baseline CVD risk, for co-morbidities and descriptors of COPD severity and impact, markers of cardiac stress (N-terminal pro–B-type natriuretic peptide, troponin T) and of inflammation (Interleukin-6), and in subgroup analysis excluding men, diabetics, current smokers or those with limited ambulation. CONCLUSIONS: In ever-smokers with COPD free of clinical CVD, GDF-15 contributes independently to subclinical coronary atherosclerosis. TRIAL REGISTRATION: ClinicalTrials.gov, NCT00608764. Registered 28 January 2008. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12931-017-0521-1) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-5331711
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-53317112017-03-06 GDF-15 plasma levels in chronic obstructive pulmonary disease are associated with subclinical coronary artery disease Martinez, Carlos H. Freeman, Christine M. Nelson, Joshua D. Murray, Susan Wang, Xin Budoff, Matthew J. Dransfield, Mark T. Hokanson, John E. Kazerooni, Ella A. Kinney, Gregory L. Regan, Elizabeth A. Wells, J. Michael Martinez, Fernando J. Han, MeiLan K. Curtis, Jeffrey L. Respir Res Research BACKGROUND: Growth differentiation factor-15 (GDF-15), a cytokine associated with cardiovascular mortality, increases during chronic obstructive pulmonary disease (COPD) exacerbations, but any role in stable COPD is unknown. We tested associations between GDF-15 and subclinical coronary atherosclerosis, assessed by coronary artery calcium (CAC) score, in COPD subjects free of clinical cardiovascular disease (CVD). METHODS: Cross-sectional analysis of COPD participants (GOLD stages 2–4) in the COPDGene cohort without CVD at enrollment, using baseline CAC (from non-EKG-gated chest computed tomography) and plasma GDF-15 (by custom ELISA). We used multinomial logistic modeling of GDF-15 associations with CAC, adjusting for demographics, baseline risk (calculated using the HEART: Personal Heart Early Assessment Risk Tool (Budoff et al. 114:1761-1791, 2006) score), smoking history, measures of airflow obstruction, emphysema and airway disease severity. RESULTS: Among 694 participants with COPD (47% women, mean age 63.6 years) mean GDF-15 was 1,304 pg/mL, and mean CAC score was 198. Relative to the lower GDF-15 tertile, higher tertiles showed bivariate association with increasing CAC score (mid tertile odds ratio [OR] 1.80, 95% confidence interval [CI] 1.29, 2.51; higher tertile OR 2.86, CI 2.04, 4.02). This association was maintained after additionally adjusting for baseline CVD risk, for co-morbidities and descriptors of COPD severity and impact, markers of cardiac stress (N-terminal pro–B-type natriuretic peptide, troponin T) and of inflammation (Interleukin-6), and in subgroup analysis excluding men, diabetics, current smokers or those with limited ambulation. CONCLUSIONS: In ever-smokers with COPD free of clinical CVD, GDF-15 contributes independently to subclinical coronary atherosclerosis. TRIAL REGISTRATION: ClinicalTrials.gov, NCT00608764. Registered 28 January 2008. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12931-017-0521-1) contains supplementary material, which is available to authorized users. BioMed Central 2017-02-28 2017 /pmc/articles/PMC5331711/ /pubmed/28245821 http://dx.doi.org/10.1186/s12931-017-0521-1 Text en © The Author(s). 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Martinez, Carlos H.
Freeman, Christine M.
Nelson, Joshua D.
Murray, Susan
Wang, Xin
Budoff, Matthew J.
Dransfield, Mark T.
Hokanson, John E.
Kazerooni, Ella A.
Kinney, Gregory L.
Regan, Elizabeth A.
Wells, J. Michael
Martinez, Fernando J.
Han, MeiLan K.
Curtis, Jeffrey L.
GDF-15 plasma levels in chronic obstructive pulmonary disease are associated with subclinical coronary artery disease
title GDF-15 plasma levels in chronic obstructive pulmonary disease are associated with subclinical coronary artery disease
title_full GDF-15 plasma levels in chronic obstructive pulmonary disease are associated with subclinical coronary artery disease
title_fullStr GDF-15 plasma levels in chronic obstructive pulmonary disease are associated with subclinical coronary artery disease
title_full_unstemmed GDF-15 plasma levels in chronic obstructive pulmonary disease are associated with subclinical coronary artery disease
title_short GDF-15 plasma levels in chronic obstructive pulmonary disease are associated with subclinical coronary artery disease
title_sort gdf-15 plasma levels in chronic obstructive pulmonary disease are associated with subclinical coronary artery disease
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5331711/
https://www.ncbi.nlm.nih.gov/pubmed/28245821
http://dx.doi.org/10.1186/s12931-017-0521-1
work_keys_str_mv AT martinezcarlosh gdf15plasmalevelsinchronicobstructivepulmonarydiseaseareassociatedwithsubclinicalcoronaryarterydisease
AT freemanchristinem gdf15plasmalevelsinchronicobstructivepulmonarydiseaseareassociatedwithsubclinicalcoronaryarterydisease
AT nelsonjoshuad gdf15plasmalevelsinchronicobstructivepulmonarydiseaseareassociatedwithsubclinicalcoronaryarterydisease
AT murraysusan gdf15plasmalevelsinchronicobstructivepulmonarydiseaseareassociatedwithsubclinicalcoronaryarterydisease
AT wangxin gdf15plasmalevelsinchronicobstructivepulmonarydiseaseareassociatedwithsubclinicalcoronaryarterydisease
AT budoffmatthewj gdf15plasmalevelsinchronicobstructivepulmonarydiseaseareassociatedwithsubclinicalcoronaryarterydisease
AT dransfieldmarkt gdf15plasmalevelsinchronicobstructivepulmonarydiseaseareassociatedwithsubclinicalcoronaryarterydisease
AT hokansonjohne gdf15plasmalevelsinchronicobstructivepulmonarydiseaseareassociatedwithsubclinicalcoronaryarterydisease
AT kazerooniellaa gdf15plasmalevelsinchronicobstructivepulmonarydiseaseareassociatedwithsubclinicalcoronaryarterydisease
AT kinneygregoryl gdf15plasmalevelsinchronicobstructivepulmonarydiseaseareassociatedwithsubclinicalcoronaryarterydisease
AT reganelizabetha gdf15plasmalevelsinchronicobstructivepulmonarydiseaseareassociatedwithsubclinicalcoronaryarterydisease
AT wellsjmichael gdf15plasmalevelsinchronicobstructivepulmonarydiseaseareassociatedwithsubclinicalcoronaryarterydisease
AT martinezfernandoj gdf15plasmalevelsinchronicobstructivepulmonarydiseaseareassociatedwithsubclinicalcoronaryarterydisease
AT hanmeilank gdf15plasmalevelsinchronicobstructivepulmonarydiseaseareassociatedwithsubclinicalcoronaryarterydisease
AT curtisjeffreyl gdf15plasmalevelsinchronicobstructivepulmonarydiseaseareassociatedwithsubclinicalcoronaryarterydisease
AT gdf15plasmalevelsinchronicobstructivepulmonarydiseaseareassociatedwithsubclinicalcoronaryarterydisease